Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin in head and neck cancer treatment
IRCT2014121920368N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of lovastatin in head and neck cancer (HNC), Oral Mucosal Carcinoma, laryngeal squamous cell carcinoma (LSCC) and 1 more, sponsored by Tehran University of Medical Sciences. Started Jun 2015; status: completed.
02
Drugs
lovastatin
03
Conditions
head and neck cancer (HNC)Oral Mucosal Carcinomalaryngeal squamous cell carcinoma (LSCC)squamous cell carcinoma of the hypopharynx
Beyond the preview
Go deeper on IRCT2014121920368N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014121920368N1.